Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum, High-Cannabidiol Treatment in an Open-label Clinical Trial-Reference-Cited by-同舟云学术

Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum, High-Cannabidiol Treatment in an Open-label Clinical Trial

Published:2021-03-01 Issue:3 Volume:78 Page:335
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Dahlgren M. Kathryn¹²³,Sagar Kelly A.¹²³,Lambros Ashley M.¹²,Smith Rosemary T.¹²,Gruber Staci A.¹²³

Affiliation:

1. Cognitive and Clinical Neuroimaging Core, McLean Hospital Imaging Center, Belmont, Massachusetts

2. Marijuana Investigations for Neuroscientific Discovery Program, McLean Hospital Imaging Center, Belmont, Massachusetts

3. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Link

https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2772629/jamapsychiatry_dahlgren_2020_ld_200012_1614611257.11051.pdf

Reference5 articles.

1. Urinary pharmacokinetic profile of cannabinoids following administration of vaporized and oral cannabidiol and vaporized CBD-dominant cannabis.;Spindle;J Anal Toxicol,2020

2. Development and validation of an Overall Anxiety Severity and Impairment Scale (OASIS).;Norman;Depress Anxiety,2006

3. Quest Diagnostics. CLIA WAIVED express results integrated multi-drug screen cup. Published 2009. Accessed August 26, 2020. http://www.questdiagnostics.com/dms/Documents/Employer-Solutions/Package-inserts/pkg_insert_clia_waived/pkg_insert_clia_waived.pdf.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabidiol (CBD) Products: Use Patterns and Perceptions Within a Sample of Anxious Users;Substance Use & Misuse;2024-06-30

2. Stability of Nano-Emulsified Cannabidiol in Acidic Foods and Beverages;Cannabis and Cannabinoid Research;2024-06-18

3. Comprehensive Insight into Cutaneous Application of Hemp;Pharmaceutics;2024-05-31

4. Pharmacokinetics and pharmacodynamics of five distinct commercially available hemp-derived topical cannabidiol products;Journal of Analytical Toxicology;2024-01-11

5. Conversion of water-soluble CBD to ∆9-THC in synthetic gastric fluid—An unlikely cause of positive drug tests;Journal of Analytical Toxicology;2023-07-13